Revive Therapeutics

Revive Therapeutics Announces Filing of FDA Pre-IND Meeting - The ...

RVV Profile

  • Sector: Health Technology
  • Industry: Pharmaceuticals: Major

Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It offers the Relicann, a proprietary hemp-based cannabidiol chewing gum for the health and wellness. Its novel cannabinoid delivery technology targets diseases and disorders such as pain, inflammation, and wound care. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada.



Recent News